Orthofix Medical Inc. (NASDAQ:OFIX) Given Consensus Recommendation of “Hold” by Brokerages

Orthofix Medical Inc. (NASDAQ:OFIX) has earned an average rating of “Hold” from the seven brokerages that are covering the firm, MarketBeat reports. One analyst has rated the stock with a sell recommendation, two have given a hold recommendation and four have given a buy recommendation to the company. The average 1 year target price among brokers that have updated their coverage on the stock in the last year is $20.00.

Several research firms have recently commented on OFIX. Stifel Nicolaus assumed coverage on shares of Orthofix Medical in a research report on Tuesday, October 28th. They set a “buy” rating and a $22.00 price target on the stock. TD Cowen began coverage on Orthofix Medical in a research report on Tuesday, January 27th. They issued a “hold” rating and a $14.00 target price on the stock. Weiss Ratings reiterated a “sell (d-)” rating on shares of Orthofix Medical in a report on Thursday, January 22nd. Finally, Barrington Research raised their price objective on Orthofix Medical from $17.00 to $18.00 and gave the stock an “outperform” rating in a research report on Wednesday, November 5th.

Insider Transactions at Orthofix Medical

In related news, CEO Massimo Calafiore sold 9,797 shares of Orthofix Medical stock in a transaction that occurred on Monday, January 12th. The shares were sold at an average price of $15.21, for a total value of $149,012.37. Following the completion of the sale, the chief executive officer owned 217,237 shares in the company, valued at approximately $3,304,174.77. This trade represents a 4.32% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, CFO Julie Andrews sold 4,873 shares of the business’s stock in a transaction that occurred on Friday, January 16th. The shares were sold at an average price of $14.38, for a total value of $70,073.74. Following the completion of the sale, the chief financial officer directly owned 58,039 shares in the company, valued at approximately $834,600.82. The trade was a 7.75% decrease in their position. The SEC filing for this sale provides additional information. Over the last quarter, insiders have sold 24,270 shares of company stock valued at $370,958. Company insiders own 1.30% of the company’s stock.

Institutional Investors Weigh In On Orthofix Medical

A number of institutional investors have recently modified their holdings of the company. CWM LLC lifted its stake in Orthofix Medical by 99.0% during the 3rd quarter. CWM LLC now owns 1,920 shares of the medical device company’s stock worth $28,000 after acquiring an additional 955 shares in the last quarter. State of Alaska Department of Revenue purchased a new stake in Orthofix Medical during the third quarter worth about $30,000. VIRGINIA RETIREMENT SYSTEMS ET Al purchased a new stake in Orthofix Medical during the second quarter worth about $147,000. Empirical Financial Services LLC d.b.a. Empirical Wealth Management lifted its position in shares of Orthofix Medical by 32.6% during the second quarter. Empirical Financial Services LLC d.b.a. Empirical Wealth Management now owns 13,297 shares of the medical device company’s stock worth $148,000 after purchasing an additional 3,271 shares in the last quarter. Finally, Mackenzie Financial Corp purchased a new position in shares of Orthofix Medical in the third quarter valued at approximately $148,000. 89.76% of the stock is owned by institutional investors and hedge funds.

Orthofix Medical Price Performance

Shares of OFIX stock opened at $13.45 on Tuesday. The company has a debt-to-equity ratio of 0.39, a current ratio of 2.47 and a quick ratio of 1.38. The company has a market capitalization of $532.62 million, a PE ratio of -4.44 and a beta of 0.79. The firm’s 50-day moving average is $15.03 and its two-hundred day moving average is $14.51. Orthofix Medical has a 12 month low of $10.24 and a 12 month high of $20.48.

About Orthofix Medical

Orthofix Medical Inc (NASDAQ: OFIX) is a global medical device company focused on the design and development of innovative orthopedic and spinal solutions. The company’s core business is divided into two segments: spine and orthopedics. In the spine segment, Orthofix offers a range of titanium implants, biologics and portable bone growth stimulation devices designed to support spinal fusion, deformity correction and minimally invasive procedures. Its orthopedic segment encompasses products for fracture fixation, external fixation systems, trauma care and sports medicine, providing surgeons with implantable devices and instruments for complex bone reconstruction and healing.

Orthofix’s product portfolio includes strut systems, bone growth stimulators, interbody fusion devices and fixation hardware that address various indications such as degenerative disc disease, spinal deformities, non-unions and long-bone fractures.